"Understanding USP 71 Sterility Tests and Extending BUD"

Size: px
Start display at page:

Download ""Understanding USP 71 Sterility Tests and Extending BUD""

Transcription

1 "Understanding USP 71 Sterility Tests and Extending BUD" ERIC S. KASTANGO, M BA, RPH, FASHP CLINICAL IQ, LLC JULY 10, 2013

2 Disclaimer Although I am an Expert Consultant to the USP, I am speaking today in my individual capacity and not as a member of the Committee or as a USP representative. The views and opinions presented are entirely my own. They do not necessarily reflect the views of USP or any other organization I may be associated with, nor should they be construed as an official explanation or interpretation of <797>. ClinicalIQ content 2013, ClinicalIQ, LLC 2

3 Understanding BUD Recognizes the probability of contamination even under best conditions: Optimal employee performance 0.1% (1 contaminated dose out of 1,000) Contamination rates published in the literature 0.3% 16% Patient Safety: Protect patients from dangerous or even fatal overgrowths of microorganisms that may have been accidentally introduced Storage time: needs to be greater than zero but less than positive infinity* (> 0 and < + ) * Personal conversation with Dr. David W. Newton, September 30, 2009 ClinicalIQ content 2013, ClinicalIQ, LLC

4 Understanding BUD For patient safety, BUD must be based on two factors: Drug s chemical stability in conjunction with Microbiological limits BUD will always be whichever is shorter Must factor in chemical stability Concern that microbial over-colonization of solutions would occur over time. ph of solution is a consideration Neutral (ph 6-8) favorable for microbial colonization ClinicalIQ content 2013, ClinicalIQ, LLC

5 Microbiological Beyond-Use Dating Risk Category Room Temp Refrigerator Freezer ( -10 C) Immediate Use 1 hour 1 hour N/A Low 48 hours 14 days 45 days Low w/12-hr BUD 12 hours or less 12 hours or less N/A Medium 30 hours 9 days 45 days High 24 hours 3 days 45 days ClinicalIQ content 2013, ClinicalIQ, LLC

6 Sterility Testing Only required when USP <797> BUD limits are exceeded or when more than 25 units of HR CSPs are prepared. NO testing is required for any risk-level CSP prepared if handled within the limits, terms and conditions described in USP Chapter <797> ClinicalIQ content 2013, ClinicalIQ, LLC

7 Process Simulation Testing (PST) It is only a point-in-time representation of: The environment The equipment The procedure The personnel involved Test Media for Suitability Sterility Growth Promotion After the incubation period is complete USP FAQs Does not recognize PST as a means of extending BUD ClinicalIQ content 2013, ClinicalIQ, LLC

8 Non-Visibility of Microbial Contamination Numbers of Bacteria per ml in 1L bottles Millipore Corp. Hospital Pharmacy Filtration Guide (Cat. No. MP801) Bedford, MA; 1980:3 ClinicalIQ content 2013, ClinicalIQ, LLC

9 What is Sterility? Free from bacteria or other microorganisms American Heritage's Definition of Sterility Within the strictest definition of sterility, a specimen would be deemed sterile only when there is complete absence of viable microorganisms from it. <1211> Sterilization and Sterility Assurance of Compendial Articles Is it possible to demonstrate complete absence of microorganisms from a CSP? Absolute sterility can t be demonstrated without the complete destruction of every article from the lot of CSPs. ClinicalIQ content 2013, ClinicalIQ, LLC 9

10 Critical Concepts of Sterilization Sterility Assurance Level (SAL) is the probability of a nonsterile item making it through the validated sterilization process. Items terminally sterilized by moist or dry heat, irradiation, or chemical sterilants have a SAL of nonsterile item per 1 million items sterilized Items prepared aseptically with a 0.22 micron filter have a SAL of nonsterile item per 1 thousand items sterilized ClinicalIQ content 2013, ClinicalIQ, LLC

11 Standard of Sterility <1> Injections Parenteral articles are prepared.to ensure they meet pharmacopeial requirements for sterility, pyrogens,... Sterility Tests Preparations for injection meet the requirements under Sterility Tests <71> ClinicalIQ content 2013, ClinicalIQ, LLC

12 Standard of Sterility Aseptic Processing from USP Chapter <1211>: While there is general agreement that sterilization of the final filled container as a dosage form or final packaged device is the preferred process for assuring the minimal risk of microbial contamination in a lot, there is a substantial class of products that are not terminally sterilized but are prepared by a series of aseptic steps. ClinicalIQ content 2013, ClinicalIQ, LLC

13 Probability The sterility of a lot purported to be sterile is therefore defined in probabilistic terms, where the likelihood of a contaminated unit or article is acceptably remote. ClinicalIQ content 2013, ClinicalIQ, LLC

14 Sterility Testing USP <71> Sterility Tests states: These Pharmacopeial procedures are not by themselves designed to ensure that a batch of product is sterile or has been sterilized. This is accomplished primarily by method suitability of the sterilization process or of the aseptic processing procedure. ClinicalIQ content 2013, ClinicalIQ, LLC

15 Understanding all of the elements Risk Level Beyond-Use Dating (point in time) Chemical Stability Microbial Stability Aseptic technique ASSUMPTION! CSP is stored at its optimal temperature at all times. Due to the inherent low probability that a Sterility Test can detect low levels of contamination in a batch, sterility assurance must always be based on process design and control. ClinicalIQ content 2013, ClinicalIQ, LLC

16 USP <71> Sterility Tests Scott Sutton, Ph.D. 41

17 Disclaimer I am making this presentation as an independent agent I am not making this presentation as a representative of USP, PDA, PMF or any other organization with which I am currently associated. The views expressed in this presentation are offered as mine alone. 2

18 Overview of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 3

19 FDA Apothecure - 03/18/2013 The Compounding Shop - 03/18/2013 Central Admixture Pharmacy Services, Livonia, Wallingford, Woburn 483 Issue Green Valley Drugs - 03/11/2013 Olympia Pharmacy - 03/04/2013 Medasus 3/18/13 Sterility Failures & Investigation Sterility Test non-compliant No sterility testing performed Sterility testing not performed on all batches Investigation of Sterility Test failures Sterility testing not performed on all batches Sample size for Sterility testing No sterility testing on finished product Bulk product released for dispensing before sterility test complete MedPREP Consulting, Inc - 3/15/13 Sterility testing not performed on all batches Investigation of Sterility Test failures Nora Apothecary and Alternative Therapies, Inc. 3/19/13 Sterility testing not performed on all batches 4 Investigation of Sterility Test failures

20 FDA Sutton, S GMP and Compounding Pharmacies. Amer Pharm Rev. 16(3): Articles/ GMP-and-Compounding-Pharmacies/ 5

21 The Press 6

22 Overview of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 7

23 Sterility Testing Two separate tests Membrane Filtration Direct Transfer 20 Units, 2 media & temperatures Requires Growth Incubation period - 14 days Moldenhauer, J and S. Sutton Towards an Improved Sterility Test. PDA J of Science and Technology 58(6):

24 Membrane Filtration Filter required amount of product through two filters Neutralize/Rinse ml volumes suggested Formulations for dilution fluids suggested One filter into Soybean Casein Digest Broth (SCDB or TSB) incubate at o C for 14 days One filter into Fluid Thioglycollate Medium (FTM) incubate at o C for 14 days 9

25 Direct Inoculation Place required amount of product into sufficient recovery medium (with neutralizers?) Soybean Casein Digest Broth (SCDB or TSB) incubate at o C for 14 days Fluid Thioglycollate Medium (FTM) incubate at o C for 14 days 10

26 Product Requirements Minimum Quantity per Unit for Each Medium Liquids Minimum Quantity < 1 ml The whole contents of each container 1-40 ml Half the contents of each container, but not less than 1 ml >40 - <100 ml 20 ml per container >100 ml 10% of the contents of the container, but not less than 20 ml Antibiotic Liquids 1 ml 11

27 Product Requirements Minimum Quantity per Unit for Each Medium Solids Minimum Quantity < 50 mg The whole contents of each container 50 - <300 mg Half the contents of each container, but not less than 50 mg 300 mg 5 g 150 mg per container >5 g 500 mg per container Insoluble preparations, creams, and ointments to be suspended or emulsified - Use the contents of each container to provide not less than 200 mg 12

28 Number of Units to be Tested 13

29 Example 1-84 units of 10 ml 10 ml is between 1 and 40 ml Table 2 tells us to use ½ volume or 5 ml per unit 84 units is less than 100 Table 3 tells us to use the greater of 4 units or 10% of the batch = 8 units per medium We therefore must test at least 5 ml from each of 8 units for each medium 14

30 Example 2 6 units of 1.5 ml 1.5 ml is between 1 and 40 ml Table 2 tells us to use ½ volume but not less than 1 ml therefore we test 1 ml ml per unit 6 units is less than 100 Table 3 tells us to use the greater of 4 units or 10% of the batch = 4 units per medium We therefore must test at least 1 ml from each of 4 units for each medium. 15

31 Overview of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 16

32 Method Suitability Test Can we neutralize any antimicrobial properties of the medication? Use specified challenge organisms Use specified total amounts of products 17

33 Method Suitability Test for Each Challenge Organism Filter maximal amount of medication to be tested Filter 2 volumes (100 ml?) of diluting fluid Add third volume, inoculate with <100 CFU challenge organism Filter Show microbial growth from filter in relevant medium at relevant temperature in 5 days 18

34 Method Suitability Test 6 challenge organisms FTM C. sporogenes P. aeruginosa S. aureus SCDB A. brasiliensis B. subtilis C. albicans 19

35 Method Suitability Examples Example 1-84 units of 10 ml 5 ml from 8 units = 40 ml for each organism; there are 6 6 x 40 ml = 240 ml total for Method Suitability Example 2 6 units of 1.5 ml 1 ml from 4 units = 4 ml for each organism 6 x 4 ml = 24 ml total for Method Suitability 20

36 Review of Presentation Who Cares? What are the compendial Sterility Tests? Product Requirements Method Suitability 21

37 Thank you for your attention Scott Sutton, Ph.D (cell)

STERILITY TESTING OF PHARMACEUTICAL PRODUCTS

STERILITY TESTING OF PHARMACEUTICAL PRODUCTS STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization

More information

Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods

Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods Microbiological Quality of Non-sterile Products Culture Media for Compendial Methods The life science business of Merck operates as MilliporeSigma in the U.S. and Canada. Culture Media for Compendial Methods

More information

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations 49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a

More information

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and

More information

Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective

Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective John W. Metcalfe, Ph.D. Senior Review Microbiologist FDA/CDER/OPQ/OPF/Division of Microbiology Assessment Center for Drug Evaluation

More information

Product Sterility Testing... To Test or Not to Test? That Is the Question

Product Sterility Testing... To Test or Not to Test? That Is the Question Product Sterility Testing... To Test or Not to Test? That Is the Question Elaine Daniell, Trabue Bryans, Kimbrell Darnell, Joyce Hansen, Victoria M. Hitchins, and Manuel Saavedra Abstract The applications

More information

Laboratorios CONDA, S.A. Distributed by Separations

Laboratorios CONDA, S.A. Distributed by Separations Culture Media as on Pharmacopoeia 7.3, Harmonized Method for Microbiological Examination of non sterile products -FORMULATIONS Buffered sodium chloride-peptone solution ph 7.0 Cat. Nº 1401 Potassium dihydrogen

More information

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW By Steven G. Richter, Ph.D 1. A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW (includes combination products) Steven G. Richter

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

Compounding Medication Regulations

Compounding Medication Regulations Association of Professors of Dermatology 2016 Annual Meeting Swissôtel, Chicago, IL Compounding Medication Regulations Christopher Bichakjian, MD Professor of Dermatology Comprehensive Cancer Center and

More information

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,

More information

USP <797> Overview and Compliance Audit Results. Joseph W. Coyne RPh Director of Field Operations Clinical IQ, LLC

USP <797> Overview and Compliance Audit Results. Joseph W. Coyne RPh Director of Field Operations Clinical IQ, LLC USP Overview and Compliance Audit Results Joseph W. Coyne RPh Director of Field Operations Clinical IQ, LLC Acknowledgements Many of the slides presented in this program come from the CriticalPoint

More information

Ingredient Listing Qty. Unit NDC # Supplier g

Ingredient Listing Qty. Unit NDC # Supplier g 8/16/2018; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Lidocaine, USP 0.400 g Stevia Powder 0.10 g Polyox TM WSR-301 Topical Adhesive Powder* 9.50 g *Formula # F 007 422 available

More information

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph..

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Objectives Describe the importance of accuracy and use of proper aseptic technique when preparing IV medications. Identify

More information

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy!

Media Fill Test Kits. Manufactured by. Making USP <797> compliance easy! Media Fill Test Kits Manufactured by Making USP compliance easy! Compliance was never so easy! Microbial Contamination Testing for CSPs Hardy Diagnostics offers all the products you need to easily

More information

1 INJECTIONS INTRODUCTION

1 INJECTIONS INTRODUCTION 1 INJECTIONS INTRODUCTION Parenteral articles are preparations intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that the active substances

More information

This chapter provides tests for the estimation of the numble, a suitable, validated adaptation of a procedure set forth

This chapter provides tests for the estimation of the numble, a suitable, validated adaptation of a procedure set forth USP 35 Dietary Supplements / 2021 Microbial Enumeration Tests 955 Dietary Supplements General Chapters Information cessitates a modification of the procedure by (1) an increase INTRODUCTION 2021 MICROBIAL

More information

2013 USP Chapter <797> Compliance Survey & Current Practice Standards

2013 USP Chapter <797> Compliance Survey & Current Practice Standards 2013 USP Chapter Compliance Survey & Current Practice Standards Kenneth S. Latta, BS, RPh Gates Healthcare Associates, Inc Hillsborough, NC We Welcome Your Questions You can submit questions throughout

More information

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml 12/20/2018; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier, USP 10 MU Sucrose, NF 23.00 g Propylene Glycol, USP 7.0 ml Medisca Oral Mix (Flavored Suspending Vehicle) 50.0 ml Medisca

More information

Legal Aspects in Intravenous Nutrient Therapy. Nayan Patel PharmD

Legal Aspects in Intravenous Nutrient Therapy. Nayan Patel PharmD Legal Aspects in Intravenous Nutrient Therapy Nayan Patel PharmD Objec;ves Understand state to state varia4on in laws to regulate office use Compounded IV Products. HR 3204; FDA jurisdic4on over compounding

More information

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,

More information

Lidocaine Hydrochloride 2%, Metronidazole 2%, Misoprostol % Topical Ointment (Suspension, 30 g) Ingredient Listing Qty. Unit NDC # Supplier

Lidocaine Hydrochloride 2%, Metronidazole 2%, Misoprostol % Topical Ointment (Suspension, 30 g) Ingredient Listing Qty. Unit NDC # Supplier 6/18/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Lidocaine Hydrochloride, USP Metronidazole, USP 0.600 g Misoprostol 1% Dispersion, USP 0.072 g Ethoxy Diglycol 3.0 ml

More information

BRIEFING 1 INJECTIONS INTRODUCTION

BRIEFING 1 INJECTIONS INTRODUCTION BRIEFING 1 Injections, USP 28 page 2201. The United States Pharmacopeia is the coordinating pharmacopeia in the efforts toward international harmonization of the specifications provided in this general

More information

Ingredient Listing Qty. Unit NDC # Supplier TBD. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier TBD. Sterile Preparation 8/16/2018; Page 1 SUGGESTED FORMULATION Acyclovir, USP Ingredient Listing Qty. Unit NDC # Supplier Mineral Oil (Light), NF 3.0 ml Polyox TM WSR-301 Oral Adhesive Paste* *Formula # F 006 397 available on

More information

1 INJECTIONS INTRODUCTION

1 INJECTIONS INTRODUCTION 1 INJECTIONS INTRODUCTION Parenteral articles are preparations intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that the active substances

More information

The Therapeutic Goods Act (1989)

The Therapeutic Goods Act (1989) EDUCATION PRACTICE UPDATE Assigning expiry dates to compounded medications First published in the Australian Journal of Pharmacy, Vol. 99, No.1169, February 2018, pp.72-76. Reproduced and distributed by

More information

SCOPE AND FIELD OF APPLICATION

SCOPE AND FIELD OF APPLICATION 1. SCOPE AND FIELD OF APPLICATION The method specifies the procedure for enumeration of aerobic mesophilic bacteria, yeast, and mould present in cosmetic products. 2. PRINCIPLE Method for enumeration of

More information

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES Association of South East Asian Nations (ASEAN) ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES Disclaimer: This document is provided for information purpose only and subject

More information

New TGA Requirements for Microbiology

New TGA Requirements for Microbiology New TGA Requirements for Microbiology Karen Longstaff Ag. Chief Microbiologist Office of Laboratories and Scientific Services September 7, 2009 ARCS: Topics to cover What s new in TGO 77 Sponsor obligations

More information

A high-level overview of the requirements of medical packaging standards

A high-level overview of the requirements of medical packaging standards Medical Packaging A high-level overview of the requirements of medical packaging standards Dec 2012 Thierry Wagner Regulatory Affairs Director Europe, Middle East and Africa DuPont Medical & Pharmaceutical

More information

Evaluation of antimicrobial effectiveness of ophthalmic drops according to the pharmacopeial tests criteria

Evaluation of antimicrobial effectiveness of ophthalmic drops according to the pharmacopeial tests criteria DARU Vol. 17, No. 1 2009 13 Evaluation of antimicrobial effectiveness of ophthalmic drops according to the pharmacopeial tests criteria 1 Samadi N., 2 Tarighi P., 1 Fazeli M.R., 3 Mehrgan H 1 Department

More information

I.C.E. Embryo Vitrification Kit

I.C.E. Embryo Vitrification Kit I.C.E. Embryo Vitrification Kit Vitrification Media V1, V2, V3 ICE Embryo Vitrification Instructions For Use Testing and Cautions Innvative Cryo Enterprises LLC 317 Springfield Road Linden, New Jersey

More information

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation 4/23/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Nifedipine, USP 0.975 g Silica Gel (Micronized) 0.75 g Medisca SPG Supposi-Base 189.06 g SPECIAL PREPARATORY CONSIDERATIONS

More information

Ingredient Listing Qty. Unit NDC # Supplier ml

Ingredient Listing Qty. Unit NDC # Supplier ml 8/28/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Progesterone 0.25%/Spironolactone 0.5% Stock Solution 5.00 ml Medisca Foamil Base 45.00 g Alcohol (95%), USP q.s. to

More information

HARMONISED PHARMACOPOEIA DEHYDRATED CULTURE MEDIA FOR SUPPORTING REGULATORY COMPLIANCE AVAILABLE NOW P O RTF O LIO.

HARMONISED PHARMACOPOEIA DEHYDRATED CULTURE MEDIA FOR SUPPORTING REGULATORY COMPLIANCE AVAILABLE NOW P O RTF O LIO. DEHYDRATED CULTURE MEDIA FOR ENHANCED P O RTF O LIO AVAILABLE NOW HARMONISED PHARMACOPOEIA SUPPORTING REGULATORY COMPLIANCE A Neogen Company THE GATEWAY TO MICROBIOLOGY INTRODUCTION Harmonised Pharmacopoeia;

More information

Technical Report No. 75 Consensus Method for Rating 0.1µm Mycoplasma Reduction Filters

Technical Report No. 75 Consensus Method for Rating 0.1µm Mycoplasma Reduction Filters Technical Report No. 75 Consensus Method for Rating 0.1µm Mycoplasma Reduction Filters PDA Consensus Method for Rating 0.1µm Mycoplasma Reduction Filters Technical Report Team Authors and Contributors

More information

Survival of Aerobic and Anaerobic Bacteria in

Survival of Aerobic and Anaerobic Bacteria in APPLIED MICROBIOLOGY, Mar. 1968, p. 445-449 Copyright 1968 American Society for Microbiology Vol. 16, No. 3 Printed in U.S.A. Survival of Aerobic and Anaerobic Bacteria in Chicken Meat During Freeze-Dehydration,

More information

Quality. Guaranteeing High Quality. Outsourced Pharmacy Services. Disclosure 3/18/2013

Quality. Guaranteeing High Quality. Outsourced Pharmacy Services. Disclosure 3/18/2013 Disclosure Outsourced Pharmacy Services By: Eddie Bostic, RPh For: South Carolina Society of Health System Pharmacist Annual Meeting, March 24 th 2013 Charleston, SC The views and opinions expressed in

More information

Ingredient Listing Qty. Unit NDC # Supplier

Ingredient Listing Qty. Unit NDC # Supplier 7/12/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Tramadol Hydrochloride, EP 0.300 g Stevia Powder 0.15 g Glycerin, USP** 3.0 ml Beef Flavor (Powder) 2.00 g Chew-A-Treat

More information

Hydrocortisone 2%, Hydroquinone 6%, Kojic Acid 4%, Salicylic Acid 4%, Tretinoin 0.01% Topical Gel (Suspension, 20 g)

Hydrocortisone 2%, Hydroquinone 6%, Kojic Acid 4%, Salicylic Acid 4%, Tretinoin 0.01% Topical Gel (Suspension, 20 g) 8/22/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Tretinoin 2% Stock Solution 0.10 ml Hydrocortisone (Micronized), USP 0.400 g Hydroquinone, USP 1.200 g Kojic Acid 0.800

More information

PDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016

PDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016 PDA Points to Consider relating to EU GMP Annex 1 changes Presented by Ashley Isbel 30 November, 2016 Lets get interactive! On your smart device, open a browser app and go to the link provided Click on

More information

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013. 21 NCAC 46.1412 PHYSICAL REQUIREMENTS A health care facility pharmacy shall have sufficient floor space allocated to it to ensure that drugs are prepared in sanitary, well lighted, and enclosed places.

More information

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products Stability of an Extemporaneously Compounded Humco s Oral Products Pradeep Gautam, MS* 1 1 Address correspondence to Pradeep Gautam, HUMCO Research and Development Laboratory, 201 W. 5 th St. Suite 1250,

More information

Ingredient Listing Qty. Unit NDC # Supplier

Ingredient Listing Qty. Unit NDC # Supplier 3/4/2015; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Lidocaine, USP 3.000 g Prilocaine, USP 3.000 g Tetracaine, USP 1.200 g Stevia Powder 0.10 g Butylated Hydroxytoluene (BHT),

More information

Draft Guidance for Industry and FDA Staff

Draft Guidance for Industry and FDA Staff Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document

More information

3.7 Bracketing. 3.8 Matrixing

3.7 Bracketing. 3.8 Matrixing chemical characteristics of the dosage form, e.g. magnesium stearate (dissolution), sodium benzoate, (microbiological preservative), etc. 3.6 Liquids Dosage forms intended for oral administration or cutaneous

More information

Vimta Labs Ltd., Life Sciences Facility, Plot No. 5, Alexandria Knowledge Park, Genome Valley, Shameerpet, Hyderabad, Telangana

Vimta Labs Ltd., Life Sciences Facility, Plot No. 5, Alexandria Knowledge Park, Genome Valley, Shameerpet, Hyderabad, Telangana Last Amended on - Page 1 of 14 I. DRUGS & PHARMACEUTICALS 1. Biological Assays Antibiotics And Other Drugs Bulk Drugs & Their Formulations: Erythromycin, Gentamicin, Nystatin IP Appendix 9.1 2.2.10 BP

More information

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier. Sterile Preparation 2/8/2014; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Baclofen, USP 1.000 g Cyclobenzaprine Hydrochloride, USP 1.000 g Diclofenac Sodium, USP 1.500 g Lidocaine Hydrochloride,

More information

October 26-30, 2003 Salt Lake City, Utah

October 26-30, 2003 Salt Lake City, Utah October 26-30, 2003 Salt Lake City, Utah High Energy Pulsed UV Light as a Sterilization Process American Association of Pharmaceutical Scientists Annual Meeting and Exposition October 27, 2003 Presented

More information

The Sterility of Reusable Instruments at Central Surgery Installation s Room Storage of One of The Hospital in Bandung

The Sterility of Reusable Instruments at Central Surgery Installation s Room Storage of One of The Hospital in Bandung The Sterility of Reusable Instruments at Central Surgery Installation s Room Storage of One of The Hospital in Bandung Insan Sunan Kurniawansyah*, Sriwidodo, Soraya Ratnawulan Mita Department of Pharmaceutical

More information

Preservation of Food. H4.2: Applies principles of food preservation to extend the life of food and maintain safety.

Preservation of Food. H4.2: Applies principles of food preservation to extend the life of food and maintain safety. Preservation of Food H4.2: Applies principles of food preservation to extend the life of food and maintain safety. Syllabus Link: What is Food Preservation? Food Preservation is the process of treating

More information

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier

SUGGESTED FORMULATION. Lot Number. Expiry Date. Ingredient Listing Qty. Unit NDC # Supplier 9/17/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Aloe Vera (Powder) (Freeze Dried) 0.200 g Tacrolimus 5% Stock Powder Blend 0.600 g Ethoxy Diglycol 1.0 ml Medisca U-Mild

More information

UNIT I EVOLUTION OF THE PHARMACY

UNIT I EVOLUTION OF THE PHARMACY Contents UNIT I EVOLUTION OF THE PHARMACY........................ 1 Chapter 1 Pharmacy History................................................. 3 Egyptian History 4 Greek Influence 4 British Apothecaries

More information

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007) November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications

More information

Rapid Sterility Testing Edited by Jeanne Moldenhauer

Rapid Sterility Testing Edited by Jeanne Moldenhauer Rapid Sterility Testing Edited by Jeanne Moldenhauer PDA Bethesda, MD, USA DHI Publishing, LLC River Grove, IL, USA 10 987654321 ISBN: 1-933722-56-8 Copyright 2011 Jeanne Moldenhauer All rights reserved.

More information

Wipe Kit. For addressing <USP 800> Hazardous Drugs - Handling in Healthcare Settings

Wipe Kit. For addressing <USP 800> Hazardous Drugs - Handling in Healthcare Settings Wipe Kit For addressing Hazardous Drugs - Handling in Healthcare Settings WipeDown 1-2-3 Technical Data File Page 2 of 10 Product Overview VAI s WipeDown 1-2-3 was designed to address the risk

More information

TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : LIP GLOSS STYLE / ITEM NO.

TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : LIP GLOSS STYLE / ITEM NO. PAGE: 1 of 5 TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ 85303 USA SAMPLE DESCRIPTION : LIP GLOSS STYLE / ITEM NO. : K3-203 BUYER : KIDS' KORNER AGE REQUESTED ON APPLICATION

More information

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT) ENG MYCO WELL D- ONE MYCO WELL D-ONE System for the presumptive identification and antimicrobial susceptibility test of urogenital mycoplasmas, Gardnerella vaginalis, Trichomonas vaginalis, Candida albicans

More information

Misconceptions with Moist Heat Sterilization Roy McLean

Misconceptions with Moist Heat Sterilization Roy McLean Misconceptions with Moist Heat Sterilization Roy McLean Senior Manager, Operations Support, R&D Sterility Assurance Baxter Healthcare Corporation 11 October 2018 1 A Famous Quote from The Big Short It

More information

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation

Ingredient Listing Qty. Unit NDC # Supplier g. Sterile Preparation Note: Glucosamine Sulfate Potassium Chloride 1267 mg is equivalent to Glucosamine 750 mg. 11/8/2016; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Chondroitin Sulfate Sodium,

More information

How Do You Know If a Sterilized Package Remains Sterile?

How Do You Know If a Sterilized Package Remains Sterile? How Do You Know If a Sterilized Package Remains Sterile? 1 Acknowledgments Bioaerosol and Applied Microbiology Team Brian Heimbuch, MS Group Lead Del Harnish, MS Lead Technical Mike McDonald, MS Lead Engineer

More information

Stability Of Extemporaneously Prepared Oral Liquid Formulations Part XI

Stability Of Extemporaneously Prepared Oral Liquid Formulations Part XI CPE CREDIT 1.0 Current & Practical Compounding Information for the Pharmacist VOLUME 20 NUMBER 1 Grant funding provided by Perrigo Pharmaceuticals Goal: To provide information on the occurrence, causes

More information

How Do You Know If Your Sterilized Instruments Remain Sterile?

How Do You Know If Your Sterilized Instruments Remain Sterile? How Do You Know If Your Sterilized Instruments Remain Sterile? Disclosure Harry Shaffer is the first author of the sterility maintenance study covered in this presentation and has been compensated by Halyard

More information

Mt. San Antonio College Microbiology 22 Lab Schedule for Spring 2018 Tues/Thurs. Split Lab Sections ONLY

Mt. San Antonio College Microbiology 22 Lab Schedule for Spring 2018 Tues/Thurs. Split Lab Sections ONLY Mt. San Antonio College Microbiology 22 Lab Schedule for Spring 2018 Tues/ Split Lab Sections ONLY Wk 1 Feb. 27 Orientation with Introductions & Safety Rules/Regulations March 1 Orientation with Pathogen

More information

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS) Association of South East Asian Nations (ASEAN) ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS) Version 3.0 CONTENTS 1. Introduction...2 2. Objective...

More information

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope IPEC Europe Observations and Recommendations on Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human

More information

ISO INTERNATIONAL STANDARD. Sterilization of health care products Radiation Part 2: Establishing the sterilization dose

ISO INTERNATIONAL STANDARD. Sterilization of health care products Radiation Part 2: Establishing the sterilization dose INTERNATIONAL STANDARD ISO 11137-2 First edition 2006-04-15 Sterilization of health care products Radiation Part 2: Establishing the sterilization dose Stérilisation des produits de santé Irradiation Partie

More information

Stability of levetiracetam oral solution repackaged in oral plastic syringes

Stability of levetiracetam oral solution repackaged in oral plastic syringes St. John Fisher College Fisher Digital Publications Doctoral External Publications 2-2014 Stability of levetiracetam oral solution repackaged in oral plastic syringes Daniel Prohotsky St. John Fisher College,

More information

Open Microphone Session on USP General Chapter <825> Radiopharmaceuticals Preparation, Compounding, Dispensing, and Repackaging

Open Microphone Session on USP General Chapter <825> Radiopharmaceuticals Preparation, Compounding, Dispensing, and Repackaging Open Microphone Session on USP General Chapter Radiopharmaceuticals Preparation, Compounding, Dispensing, and Repackaging October 10, 2018 11:00 am 1:00 pm ET General Chapter Open Microphone

More information

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1

Lab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1 Lab 4. Blood Culture (Media) 2018 320 MIC AMAL-NORA-ALJAWHARA 1 Blood Culture 2018 320 MIC AMAL-NORA-ALJAWHARA 2 What is a blood culture? A blood culture is a laboratory test in which blood is injected

More information

Stonegate Pharmacy LP 11/10/16

Stonegate Pharmacy LP 11/10/16 Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite

More information

H.Pylori IgM Cat # 1504Z

H.Pylori IgM Cat # 1504Z DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Healthcare Sterilisation: Introduction and Standard Practices, Volume 1

Healthcare Sterilisation: Introduction and Standard Practices, Volume 1 Contents 1. Overview of Sterilisation and Background... 1 1.1 Magic Wand... 1 1.1.1 Definition of Sterilisation... 2 1.1.2 Detectives or Forensic Scientists... 3 1.1.3 Idealised Process... 6 1.1.4 Lesser

More information

Town and Country Compounding and Consultation Services, LLC 10/17/17

Town and Country Compounding and Consultation Services, LLC 10/17/17 Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)

More information

TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : HAND SANITIZER BUDDY WITH HAND SANITIZER

TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ USA SAMPLE DESCRIPTION : HAND SANITIZER BUDDY WITH HAND SANITIZER PAGE: 1 of 6 TEST REPORT APPLICANT : CSP INC ADDRESS : 8248 W. ORANGE DR GLENDALE, AZ 85303 USA SAMPLE DESCRIPTION : HAND SANITIZER BUDDY WITH HAND SANITIZER STYLE / ITEM NO. : K5-506 BUYER : KIDS' KORNER

More information

Allergy Vial Preparations and USP 797. Donald W Aaronson MD JD MPH

Allergy Vial Preparations and USP 797. Donald W Aaronson MD JD MPH Allergy Vial Preparations and USP 797 Donald W Aaronson MD JD MPH Compounded Sterile Preparations (CSP) = USP 797 History Compliance with USP 797 has always been in the law with respect to physicians offices

More information

Model Standards for Pharmacy Compounding of Non-Sterile Preparations

Model Standards for Pharmacy Compounding of Non-Sterile Preparations Model Standards for Pharmacy Compounding of Non-Sterile Preparations Published with the Guidance Document For Pharmacy Compounding of Non-Sterile Preparations National Association of Pharmacy Regulatory

More information

Experience of paediatric formulations in Marketing Authorisatrion Applications

Experience of paediatric formulations in Marketing Authorisatrion Applications Experience of paediatric formulations in Marketing Authorisatrion Applications Elisabeth RICCHI Senior Quality Assessor 1 Overview of the presentation Formulation Measuring device Reconstitution packaging

More information

Sterilization of health care products Radiation. Part 2: Establishing the sterilization dose

Sterilization of health care products Radiation. Part 2: Establishing the sterilization dose Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 11137-2 Third edition 2013-06-01 Sterilization of health care products Radiation Part 2: Establishing the sterilization dose Stérilisation des

More information

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com H. pylori

More information

3/2/2018. Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC Learning Objectives. Rule Compliance is Stimulating

3/2/2018. Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC Learning Objectives. Rule Compliance is Stimulating Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC cdembny2@gmail.com Learning Objectives Rule Compliance is Stimulating 1 Biography 2 3 This is a broad and confusing issue for many centers. Information

More information

גדות תעשיות ביוכימיה בע"מ Gadot Biochemical Industries Ltd.

גדות תעשיות ביוכימיה בעמ Gadot Biochemical Industries Ltd. General Characteristics: Formula: Ca 3(C6H5O7(2 *4H2O Molecular weight: 570.6 Appearance: Fine white free flowing powder Odor: Odorless Solubility: In water - Almost insoluble In alcohol - Insoluble CAS

More information

SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING

SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING Menu Surface monitoring using ChemSwab Air Monitoring using Coriolis µ Bioburden in raw materials and intermediates 2 Menu Surface monitoring using ChemSwab

More information

PARENTERAL PREPARATIONS

PARENTERAL PREPARATIONS PARENTERAL PREPARATIONS INTRODUCTION Parenteral (Gk, para enteron, beside the intestine) dosage forms differ from all other drug dosage forms, because they are injected directly into body tissue through

More information

Evaluation of a Waterless, Scrubless Chlorhexidine Gluconate/Ethanol Surgical Scrub for Antimicrobial Efficacy

Evaluation of a Waterless, Scrubless Chlorhexidine Gluconate/Ethanol Surgical Scrub for Antimicrobial Efficacy Evaluation of a Waterless, Scrubless Chlorhexidine Gluconate/Ethanol Surgical Scrub for Antimicrobial Efficacy by G. Mulberry 1 A. Snyder 2 J. Stahl, J. Heilman and J. Pyrek 3 1 Hill Top Research, Inc.,

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017

320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017 320 MBIO Microbial Diagnosis Aljawharah F. Alabbad Noorah A. Alkubaisi 2017 Blood Culture What is a blood culture? A blood culture is a laboratory test in which blood is injected into bottles with culture

More information

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017 Environmental Monitoring How to Satisfy the Regulator Presented by Tanja Varglien, July 2017 Slide 1 PharmOut 2017 Using Glisser You will be able to tap the download link at the end of each presentation.

More information

H.pylori IgA Cat #

H.pylori IgA Cat # DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Food Contamination and Spoilage Food Safety: Managing with the HACCP System Second Edition (245TXT or 245CIN)

Food Contamination and Spoilage Food Safety: Managing with the HACCP System Second Edition (245TXT or 245CIN) Food Contamination and Spoilage Food Safety: Managing with the HACCP System Second Edition (245TXT or 245CIN) 2008, Educational Institute Competencies for Food Contamination and Spoilage 1. Distinguish

More information

905 UNIFORMITY OF DOSAGE UNITS

905 UNIFORMITY OF DOSAGE UNITS Change to read: 905 UNIFORMITY OF DOSAGE UNITS [ NOTE In this chapter, unit and dosage unit are synonymous. ] To ensure the consistency of dosage units, each unit in a batch should have a drug substance

More information

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries. Leader in custom manufacturing for the pharmaceutical and nutraceutical industries. Since its inception in April 1994, Viva Pharmaceutical Inc. has built a reputation as a leading manufacturer committed

More information

Parametric Release Regulatory Requirements. Terry E. Munson Technical Vice President PAREXEL International, LLC

Parametric Release Regulatory Requirements. Terry E. Munson Technical Vice President PAREXEL International, LLC Parametric Release Regulatory Requirements Terry E. Munson Technical Vice President History First application approved for parametric release in 1985 Formed the basis for the FDA Compliance Policy Guide

More information

[ 11 C]Mes-IMPY FOR INJECTION: CERTIFICATES OF ANALYSIS

[ 11 C]Mes-IMPY FOR INJECTION: CERTIFICATES OF ANALYSIS Table of Contents COA # Name Page Ware 1 COA of analytical column 3 2 COA of semi-prep column 4 3 COA of Millex GV 4 mm vent filter 5 4 COA of MiIlex MP 25 mm Sterile Filter 6 5 Sterile empty vial 7-9

More information

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20 Chapter 20 Intrathecal Preparations By the end of this chapter, you will be able to: l Describe the specific risks with intrathecal cytotoxic products l List five checks that need to be carried out on

More information

H.Pylori IgG Cat # 1503Z

H.Pylori IgG Cat # 1503Z DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

The USP and Compounding Nonsterile Medications

The USP and Compounding Nonsterile Medications November 21, 2015 Association of Portuguese Hospital Pharmacists The USP and Compounding Nonsterile Medications Lisa D. Ashworth, BS Pharm, RPh, FACA Compounding Specialist and Clinical Pharmacist, Children

More information

Microbial quality of some herbal solid dosage forms

Microbial quality of some herbal solid dosage forms African Journal of Biotechnology Vol. 9 (11), pp. 1701-1705, 15 March, 2010 Available online at http://www.academicjournals.org/ajb ISSN 1684 5315 2010 Academic Journals Full Length Research Paper Microbial

More information